Oruka Therapeutics, Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

10.95

-0.90 (-7.59%)

At close: May 30, 2025, 4:00 PM

10.96

+0.01 (0.09%)

After-hours: May 30, 2025, 4:20 PM EDT

Oruka Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	17.74	14.25
Research & Development	95.74	81.01
Operating Expenses	113.48	95.26
Operating Income	-113.48	-95.26
Interest Expense	-1.39	-1.6
Interest & Investment Income	10.49	6.4
Other Non Operating Income (Expenses)	-0	0
EBT Excluding Unusual Items	-104.38	-90.46
Other Unusual Items	-0.87	-0.87
Pretax Income	-105.26	-91.34
Net Income	-105.26	-91.34
Preferred Dividends & Other Adjustments	-24.9	-20.39
Net Income to Common	-80.35	-70.95
Shares Outstanding (Basic)	26	17
Shares Outstanding (Diluted)	26	17
EPS (Basic)	-3.04	-4.23
EPS (Diluted)	-3.04	-4.23
Free Cash Flow	-84.02	-63.3
Free Cash Flow Per Share	-3.18	-3.77
EBITDA	-	-95.23
D&A For EBITDA	-	0.03
EBIT	-113.48	-95.26

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q